Proposition - PharmXpert Academy

More documents

Recommendations

Info

The Korean Pharmaceutical Company List 515 3. R&D Figures ◦For Strategic Targets of Research in Future - Development of Biocompatible drugs which fusioned TDDS drugs with BioTechnologies (B T) - Research for sophisticated drug forms which might have specific therapeutic effects against chronic and incurable diseases. - Contriving drugs to do the utmost convinientness for customers by reducing the frequencies to apply the drugs through extending the duration of effectiveness with drugs 4. Patent Information No 1 2 The Name of Technology Brains fatigue improvement a composite and sticking a medicine) The composition of base for a hydrated plaster) Application No. (Application date) 10-2003- 0077373 10-1999- 0023321 Publication No. (Publication date) Priority No. Applied Country For Global Development Stage Future Plan 2004-0012618 - commercialization commercialization 1999-0073204 - commercialization commercialization 3 pas 1999-0009526 1999-0035094 - none none Expected Licencing (Domestic, Oversea)
516 2007 Korea Pharmaceutical Industry Directory 64. SK Chemicals 1. Company Information Company SK Chemicals Representative Kim, Chang-Geun E-mail Representative Representative 82-2-2008-2008 Phone No. Fax No. 82-2-2008-2009 Hompage www.SKchemicals.com Address 948-1,Daechi3-dong, Gangnam-gu, Seoul, 135-847,Korea Research Institute Address 600, Jeongja-dong, Jangan-gu,Suwon-si, Gyeonggi-do Year of Establishment 1969 Sales (‘06) 256.3 Million$ The Number of Total The Number of Total Employees (06‘) 819 Researcher (‘06) 73 Contact Person Seo, Dong Jin Contact Phone Contact E-mail Contact Fax Introduction of Company Since established in 1969, the SK Chemicals, having settled down as a chemical company to represent Korea, is making the future of happy harmony between human beings and environments by developing eco-friendly chemical products to make our lives safe and healthy based on its accumulated technical capability. SK Chemicals is newly changing by establishing a vision based on specialty chemicals and life science business since separation of textile business in 2000. The specialty chemicals business is producing continuous outcomes in polyurethane, biocide, water treatment chemical products, etc. as well as the high functional PETG resin developed for the second time in the world, and is recently making an effort to maximize future business values while positively excavating new business by advancing into a new business field such as information-electronic materials, functional cosmetics, etc. The life science business is recording continuous sales expansion such as Sunpla the domestic new drug No.1 anti-cancer medicine, Trast the arthritis medicine of domestic market share ranking 1st, Joins the domestic natural new drug No.1, etc. Also in the future, the life science part of SK Chemicals will be making the best merchandise through the synergy of R&D and production/ sales networks connected to Marketing, Life Science Research Institute and Dongshin Pharmaceuticals. More accelerating the globalization strategy, SK Chemicals is already securing overseas production bases at Indonesia and China, and is planning to focus the company’s capability on being furnished with global competitiveness in all business fields in the long term in order to more expand the business to advance into China along with successful launching of the Poland plant, which is expected to be completed in 2005. In the future, SK Chemicals will be reborn as a top-ranking company to lead the changes in the 21st century by focusing its capability on the specialty chemicals field such as environmental materials, industrial materials, information communications materials, etc. and the life science field such as synthetic medicines, natural medicines, biotech, etc. based on the stable profit creation of petrochemical and resin business, which is its current main business
Page 2 and 3:
2007 Korea Pharmaceutical Industry
Page 4 and 5:
2007 Korea Pharmaceutical Industry
Page 6 and 7:
27. ILYANG PHARM ·········
Page 8 and 9:
Chapter 1. Outline of The Project 2
Page 10 and 11:
Chapter 1. Outline of The Project 2
Page 12 and 13:
Chapter 2. Pharmaceutical Industry
Page 14 and 15:
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
The Annex
Page 38 and 39:
316 2007 Korea Pharmaceutical Indus
Page 40 and 41:
The Korean Pharmaceutical Company L
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
4. Company Map The Korean Pharmace
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
Page 178 and 179:
Page 180 and 181:
Page 182 and 183:
Page 184 and 185:
Page 186 and 187: The Korean Pharmaceutical Company L
Page 200 and 201: 4. Company Map The Korean Pharmace
show all

Proposition - PharmXpert Academy

Create successful ePaper yourself

Delete template?

Save as template?